Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paclitaxel (TAXOL): side effects and patient education issues

F E Walker1

  • 1Ambulatory Care Department, Fox Chase Cancer Center, Philadelphia, PA 19111.

Seminars in Oncology Nursing
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guiding patients and their families through peripheral stem cell transplantation with the help of a teaching booklet.

Oncology nursing forum·1994
Same author

A new gastric carcinoma cell line (LIM1839) derived from a young Caucasian male.

International journal of cancer·1989
Same author

STD testing of suspected sexually abused children at a pediatric hospital.

Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada·1988
Same author

Similarity and differences between conditions for initiation and failure of detonation.

Proceedings of the National Academy of Sciences of the United States of America·1980
Same author

Traumatic periodontal disturbances, diagnosis and treatment planning.

The Chronicle·1972
Same author

Let's be practical about "mobility".

The Chronicle·1972

Paclitaxel (TAXOL) is an antimicrotubule chemotherapy effective for ovarian, breast, and lung cancers. This article details its side effects, patient risks, and management strategies.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Paclitaxel (TAXOL) is an antimicrotubule agent.
  • It is indicated for metastatic ovarian carcinoma post-chemotherapy failure.
  • Positive responses observed in breast and lung cancers.

Purpose of the Study:

  • To describe reported side effects of paclitaxel.
  • To outline preventive measures, manifestations, at-risk patients, and management of adverse reactions.
  • To discuss patient education regarding paclitaxel treatment.

Main Methods:

  • Review of reported side effects in various clinical settings.
  • Analysis of preventive strategies and management protocols.
  • Assessment of patient education requirements.

Related Experiment Videos

Main Results:

  • Detailed descriptions of paclitaxel side effects.
  • Identification of patient populations at higher risk.
  • Guidance on managing adverse events and patient education.

Conclusions:

  • Effective management of paclitaxel side effects is crucial.
  • Comprehensive patient education enhances treatment adherence and outcomes.
  • Understanding risks and management is key for successful paclitaxel therapy.